{
  "trial_id": "NCT02086825",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age 18 years or older",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Cirrhosis of the liver based on biopsy or clinical and radiographic criteria",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Ability to provide informed consent (Grade 0 to 1 HE)",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Previous history of sensitivity/allergy to lactulose or rifaximin or rifampin",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Pregnancy",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has cirrhosis, grade II esophageal varices, and recent admission for UGIB. He is being treated with lactulose.",
  "_meta": {
    "topic_id": "7",
    "trial_id": "NCT02086825",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}